Costa rica launches national registry to track rare skin disease
NCT ID NCT07448428
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study creates a national registry for people with generalized pustular psoriasis (GPP) in Costa Rica. Researchers will collect information from about 50 patients to better understand the disease, how it progresses, and what treatments are used. The goal is to improve care for this rare and serious skin condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED PUSTULAR PSORIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Caja Costarricense del Seguro Social
San José, Provincia de San José, 40901, Costa Rica
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI boosts doctor accuracy for rare skin diseases in new study
- New registry aims to unlock secrets of rare skin disease GPP
- New injection aims to stop dangerous psoriasis flares in their tracks
- New drug spesolimab under Real-World watch for rare skin disease
- Psoriasis flare drug study pulled before it began
- New pill shows promise for rare, severe psoriasis